| An accountancy practice http://www.abramus.org.br/unidades/rj/ lisinopril 12.5 hctz The drug consists of a corticosteroid to reduce inflammation and a novel long-acting beta-agonist (LABA), which is designed to open the airways. While the U.S. approval so far only covers the treatment of chronic obstructive pulmonary disease (COPD), the European recommendation is for both asthma and COPD.
|